Phospho-AIRE (Ser156) Antibody

What is AIRE protein and why is its phosphorylation at Ser156 significant?

AIRE (Autoimmune Regulator) functions as a transcription factor that plays an essential role in promoting self-tolerance in the thymus by regulating the expression of tissue-restricted antigens (TRAs). These TRAs share the commonality of being tissue-restricted in their expression pattern in the periphery . The phosphorylation of AIRE at Ser156 is particularly significant as it influences AIRE's transactivation ability. Research has demonstrated that DNA-Dependent Protein Kinase (DNA-PK) contributes to the phosphorylation of AIRE at specific residues including Thr68 and Ser156 . This post-translational modification appears to be crucial for proper AIRE function, as mutations introduced into these phosphorylation sites decrease AIRE's capacity to activate transcription from reporter promoters . Additionally, phosphorylation could potentially trigger oligomerization of AIRE proteins, further affecting their functional properties .

How does Phospho-AIRE (Ser156) antibody specifically detect the phosphorylated form of AIRE?

The Phospho-AIRE (Ser156) antibody is designed to recognize AIRE protein only when phosphorylated at serine 156. This specificity is achieved through a carefully controlled production process. The antibody is typically generated by immunizing rabbits with a synthetic phosphopeptide derived from the human AIRE sequence surrounding the phosphorylation site of Ser156 (often described as P-G-S(p)-Q-L) . The antibody is then purified through affinity chromatography using epitope-specific phosphopeptides. Importantly, non-phospho-specific antibodies are removed during purification by chromatography using non-phosphopeptides . This production method ensures that the resulting antibody detects endogenous levels of AIRE-1 protein exclusively when it is phosphorylated at the S156 position, making it a valuable tool for studying the specific phosphorylation state of AIRE in various experimental conditions.

What are the optimal conditions for Western blot analysis using Phospho-AIRE (Ser156) antibody?

For Western blot applications using Phospho-AIRE (Ser156) antibody, researchers should consider the following methodological approach:

For enhanced detection specificity, include both phosphorylated and non-phosphorylated control peptides in parallel experiments. This approach allows confirmation that the signal detected is specifically from phosphorylated AIRE at Ser156 rather than non-specific binding. Additionally, sample dephosphorylation with lambda phosphatase can serve as a negative control to validate antibody specificity .

How should researchers design experiments to study the functional implications of AIRE phosphorylation at Ser156?

When investigating the functional implications of AIRE phosphorylation at Ser156, researchers should consider a multi-faceted experimental approach:

• Site-directed mutagenesis: Generate phospho-mimetic (S156D/E) and phospho-dead (S156A) mutants of AIRE to study the functional consequences of constitutive phosphorylation or lack of phosphorylation at this site.

• Transcriptional activity assays: Utilize reporter gene constructs containing AIRE-responsive promoters to compare the transactivation capacity of wild-type AIRE versus the phospho-mutants. Research has shown that mutations at phosphorylation sites (including Ser156) decrease AIRE's ability to activate transcription from reporter promoters .

• Protein-protein interaction studies: Investigate how phosphorylation at Ser156 affects AIRE's interaction with known binding partners, particularly components of the DNA-PK complex (Ku70, Ku80, DNA-PKcs). Co-immunoprecipitation assays and GST pull-down experiments can be employed for this purpose .

• ChIP-seq analysis: Compare chromatin binding profiles of wild-type AIRE versus phospho-mutants to determine if Ser156 phosphorylation influences AIRE's genomic targeting.

• Subcellular localization studies: Examine whether phosphorylation status affects AIRE's nuclear/cytoplasmic distribution or its association with nuclear bodies using immunofluorescence microscopy with phospho-specific antibodies.

Research has established that DNA-PK contributes to the phosphorylation of AIRE at Thr68 and Ser156, influencing AIRE's transactivation ability . Additionally, as phosphorylation may trigger oligomerization of AIRE proteins , analytical ultracentrifugation or size-exclusion chromatography could be employed to assess how Ser156 phosphorylation affects AIRE's oligomeric state.

How can cell-based ELISA techniques be optimized for quantifying AIRE phosphorylation at Ser156?

Cell-based ELISA represents a powerful technique for quantifying AIRE phosphorylation levels in cultured cells without the need for cell lysate preparation. To optimize this approach:

• Cell density optimization: Seed cells at various densities (2,500-20,000 cells/well) to determine the optimal cell number that provides robust signal while maintaining cell health.

• Fixation and permeabilization: Test different fixation methods (4% paraformaldehyde vs. methanol) and permeabilization reagents (0.1-0.5% Triton X-100 vs. 0.1% saponin) to maximize antibody accessibility while preserving epitope integrity.

• Blocking and antibody incubation: Utilize a blocking solution containing 1-5% BSA or normal serum from the same species as the secondary antibody. For Phospho-AIRE (Ser156) antibody, typical dilutions for cell-based ELISA range from 1:1000 to 1:5000 .

• Signal normalization: To account for variations in cell number, normalize phospho-AIRE signal to total cell content using a cell-staining dye (e.g., Janus Green) or to total AIRE protein using a non-phospho-specific AIRE antibody.

• Controls: Include appropriate controls such as:

  • Unstimulated cells (baseline phosphorylation)

  • Cells treated with phosphatase inhibitors (enhanced phosphorylation)

  • Cells treated with lambda phosphatase (reduced phosphorylation)

  • Secondary antibody-only controls (background signal)

The AIRE (Phospho-Ser156) Colorimetric Cell-Based ELISA Kit provides a convenient, lysate-free, high throughput and sensitive assay that can monitor AIRE protein phosphorylation in cells . This approach enables researchers to measure relative amounts of phosphorylated AIRE in cultured cells and screen for effects of various treatments, inhibitors (e.g., siRNA or chemicals), or activators on AIRE phosphorylation status .

What are the methodological considerations for studying the kinetics of AIRE phosphorylation and dephosphorylation?

Investigating the dynamic regulation of AIRE phosphorylation requires specific methodological approaches:

• Time-course experiments: Treat cells with stimuli known to activate DNA-PK (e.g., DNA damaging agents) and harvest at multiple time points (5 min to 24 hours) to monitor the kinetics of Ser156 phosphorylation.

• Pulse-chase analysis: Use phosphatase inhibitors as a pulse to accumulate phosphorylated AIRE, then remove inhibitors and monitor the rate of dephosphorylation over time.

• Pharmacological inhibitors: Employ specific inhibitors of DNA-PK (e.g., NU7441, KU-57788) to confirm the role of this kinase in mediating AIRE Ser156 phosphorylation. Compare with inhibitors of other kinases (PKA, PKC, CK2) to establish specificity.

• Mass spectrometry-based approaches: Utilize stable isotope labeling with amino acids in cell culture (SILAC) combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) to quantitatively monitor phosphorylation dynamics at Ser156 and potential cross-talk with other post-translational modifications.

• In vitro kinase assays: Reconstruct the phosphorylation reaction in vitro using purified components (DNA-PK complex and recombinant AIRE) to establish direct causality and reaction kinetics. Research has demonstrated through in vitro phosphorylation assays that residues Thr68 and Ser156 are DNA-PK phosphorylation sites in AIRE .

When designing these experiments, it's crucial to consider that phosphorylation could trigger oligomerization of AIRE proteins , potentially creating feedback loops in the phosphorylation dynamics. Additionally, the expression of DNA-PKcs in AIRE-positive medullary thymic epithelial cell (mTEC) populations suggests that physiologically relevant studies should focus on these cell types or models that recapitulate their biology.

How can researchers validate the specificity of Phospho-AIRE (Ser156) antibody signals in their experimental system?

Validating antibody specificity is critical for reliable interpretation of phosphorylation data. For Phospho-AIRE (Ser156) antibody, consider these validation approaches:

• Peptide competition assay: Pre-incubate the antibody with excess phosphorylated peptide (containing pSer156) and non-phosphorylated peptide in parallel experiments. Signal elimination by the phospho-peptide but not by the non-phospho peptide confirms specificity.

• Phosphatase treatment: Treat half of your sample with lambda phosphatase before immunoblotting. Disappearance of the signal in treated samples confirms detection of phosphorylated rather than non-phosphorylated AIRE.

• Genetic models: Use AIRE knockout cells/tissues as negative controls. Additionally, express wild-type AIRE and S156A mutant in AIRE-deficient cells; the antibody should detect only the wild-type protein.

• Phosphorylation induction: Stimulate cells with DNA damage inducers to activate DNA-PK and enhance AIRE phosphorylation. An increase in signal intensity supports antibody specificity for the phosphorylated form.

• Multiple antibody approach: Compare results using antibodies from different sources or raised against different epitopes surrounding pSer156 to confirm consistency of findings.

The specificity of Phospho-AIRE (Ser156) antibody is established during its production process. Antibodies are typically purified by affinity-chromatography using epitope-specific phosphopeptides, and non-phospho specific antibodies are removed by chromatography using non-phosphopeptides . Nevertheless, validation in each experimental system remains essential due to potential matrix effects and cross-reactivity with other phosphorylated proteins.

What potential confounding factors should researchers consider when interpreting phosphorylation data from different experimental conditions?

When interpreting AIRE phosphorylation data, researchers should account for several potential confounding factors:

• AIRE expression levels: Changes in total AIRE protein levels can influence phosphorylation signal intensity independent of actual phosphorylation status. Always normalize phospho-AIRE signal to total AIRE protein levels.

• Cell cycle effects: DNA-PK activity varies throughout the cell cycle, potentially affecting AIRE phosphorylation patterns. Synchronize cells or account for cell cycle distribution when comparing experimental conditions.

• Phosphatase activity: Variations in endogenous phosphatase activity can affect steady-state phosphorylation levels. Consider including phosphatase inhibitors during sample preparation to preserve phosphorylation status.

• Cross-talk with other post-translational modifications: AIRE undergoes multiple post-translational modifications (acetylation, SUMOylation, ubiquitination) that may influence antibody accessibility to the pSer156 epitope or affect phosphorylation status indirectly.

• Subcellular localization: AIRE shuttles between nuclear and cytoplasmic compartments, with potentially different phosphorylation patterns in each location. Consider subcellular fractionation to resolve compartment-specific phosphorylation states.

• Artificial phosphorylation during sample processing: Stress during cell harvesting or lysis can activate kinases, creating artifactual phosphorylation. Employ rapid lysis techniques and maintain samples at cold temperatures.

• Antibody cross-reactivity: Despite purification efforts, antibodies may recognize similar phospho-epitopes on other proteins. Validate findings using orthogonal approaches such as mass spectrometry.

Research has established that mutations in AIRE phosphorylation sites decrease the capacity of AIRE to activate transcription from reporter promoters . Therefore, when studying functional outcomes of phosphorylation, consider that observed effects may be due to altered AIRE transcriptional activity rather than changes in other aspects of AIRE function.

How can Phospho-AIRE (Ser156) antibody be used to investigate the relationship between DNA damage response and autoimmunity?

The connection between DNA damage response and autoimmunity can be explored using Phospho-AIRE (Ser156) antibody through several sophisticated experimental approaches:

• DNA damage response integration: Since DNA-PK is a key component of the DNA damage response machinery, investigate how various types of DNA damage (ionizing radiation, UV, genotoxic chemicals) affect AIRE phosphorylation at Ser156. This approach can reveal how genomic stress signals are integrated into autoimmune regulation.

• Tissue-specific analysis: Examine phospho-AIRE levels in thymic medullary epithelial cells (mTECs) from mouse models with defects in DNA repair pathways (e.g., ATM-/-, DNA-PKcs-/-, XRCC4-/-). Correlate phosphorylation patterns with alterations in tissue-restricted antigen expression and autoimmune phenotypes.

• Patient-derived samples: Compare phospho-AIRE (Ser156) levels in thymic tissue or peripheral blood mononuclear cells from APECED patients with different AIRE mutations versus healthy controls. This approach may reveal whether certain mutations affect AIRE phosphorylation status indirectly.

• ChIP-seq following DNA damage: Perform chromatin immunoprecipitation using Phospho-AIRE (Ser156) antibody before and after DNA damage induction to map genome-wide binding sites of phosphorylated AIRE. Compare with total AIRE ChIP-seq to determine if phosphorylation redirects AIRE to specific genomic regions.

• Mechanistic links to transcription: Investigate whether DNA-PK-mediated phosphorylation of AIRE at Ser156 affects its interaction with histone H3 that is not methylated at 'Lys-4', not phosphorylated at 'Thr-3' and not methylated at 'Arg-2' . This could reveal how DNA damage signaling alters AIRE's function as a sensor of histone modifications.

Research has established that DNA-PK contributes to the phosphorylation of AIRE at Thr68 and Ser156, influencing AIRE's transactivation ability . Given that DNA-PKcs is expressed in AIRE-positive mTEC cell populations , exploring this relationship could provide novel insights into how DNA damage responses in the thymus might influence central tolerance mechanisms and potentially contribute to autoimmune disease pathogenesis.

What approaches can be used to investigate the structural consequences of AIRE phosphorylation at Ser156?

Investigating the structural impact of Ser156 phosphorylation on AIRE requires sophisticated biophysical and computational approaches:

• X-ray crystallography or Cryo-EM: Compare structures of recombinant AIRE domains (particularly the region spanning amino acids 126-175) in phosphorylated and non-phosphorylated states to visualize conformational changes induced by Ser156 phosphorylation.

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS): This technique can identify regions of AIRE that undergo altered solvent accessibility or conformational dynamics upon Ser156 phosphorylation, providing insights into allosteric effects.

• Circular dichroism (CD) spectroscopy: Monitor changes in secondary structure content of AIRE fragments containing Ser156 before and after in vitro phosphorylation to determine if phosphorylation alters the protein's folding properties.

• Analytical ultracentrifugation and size-exclusion chromatography coupled with multi-angle light scattering (SEC-MALS): These techniques can assess whether Ser156 phosphorylation affects AIRE's oligomerization state, as phosphorylation could trigger oligomerization of AIRE proteins .

• Nuclear magnetic resonance (NMR) spectroscopy: For smaller AIRE domains or peptides containing Ser156, NMR can provide atomic-level insights into structural perturbations caused by phosphorylation.

• Molecular dynamics simulations: Computational modeling of AIRE protein domains with and without phosphorylation at Ser156 can reveal dynamic structural changes that may not be captured by static experimental techniques.

• Cross-linking mass spectrometry: This approach can identify changes in proximity between different regions of AIRE upon Ser156 phosphorylation, providing information about large-scale conformational rearrangements.

Research indicates that phosphorylation could trigger oligomerization of AIRE proteins , suggesting that Ser156 phosphorylation may play a critical role in regulating AIRE's quaternary structure. Understanding these structural consequences is essential for elucidating how phosphorylation mechanistically influences AIRE's function as a transcriptional regulator promoting self-tolerance in the thymus.

What are common problems encountered when using Phospho-AIRE (Ser156) antibody in Western blotting, and how can they be resolved?

When working with Phospho-AIRE (Ser156) antibody in Western blotting, researchers may encounter several challenges that can be systematically addressed:

For optimal results, researchers should store the antibody at -20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles . The recommended dilution range for Western blotting is typically 1:500-1:2000 , but optimization for specific experimental conditions is advised. Additionally, using phosphorylated peptide competition assays can help distinguish specific from non-specific signals.

How can researchers optimize phospho-specific signal detection when AIRE expression levels are low?

Detecting phosphorylated AIRE in samples with low expression levels requires specialized strategies:

• Sample enrichment techniques:

  • Immunoprecipitate total AIRE first, then probe with phospho-specific antibody

  • Use subcellular fractionation to concentrate nuclear proteins where AIRE predominantly localizes

  • Employ phosphoprotein enrichment methods (e.g., metal oxide affinity chromatography) prior to Western blotting

• Signal amplification methods:

  • Utilize more sensitive detection systems (e.g., enhanced chemiluminescence plus, fluorescent secondary antibodies)

  • Consider tyramide signal amplification for immunohistochemistry applications

  • Employ biotin-streptavidin amplification systems

• Protocol optimization:

  • Increase protein loading (up to 100 μg per lane)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Reduce washing stringency slightly to preserve weak signals

  • Use PVDF membranes instead of nitrocellulose for higher protein binding capacity

• Alternative detection methods:

  • Switch to more sensitive ELISA-based detection (detection limit can be 10-100 fold lower than Western blotting)

  • Consider Phospho-AIRE (Ser156) Colorimetric Cell-Based ELISA Kit for intact cell analysis

  • Employ proximity ligation assay (PLA) which can detect single phosphorylation events with high sensitivity

• Cell manipulation strategies:

  • Transiently overexpress AIRE in relevant cell types

  • Treat cells with phosphatase inhibitors to increase steady-state phosphorylation levels

  • Stimulate DNA-PK activity through controlled DNA damage to enhance AIRE phosphorylation

When working with clinical samples or rare cell populations where AIRE expression is limited, combining multiple approaches (e.g., immunoprecipitation followed by high-sensitivity Western blotting) may be necessary to reliably detect phosphorylated AIRE at Ser156.